The externalized HMGB1 interacts with receptor for advanced glycation end products (RAGE) on GBM cells, resulting in the activation of the transcription factor NF-κB, which in turn enhances the expression and secretion of IL-8. This evidence concerns the gene CXCL8 and glioblastoma.